...the purpose of our study was to explore the role of FAT2 mutations for predicting prognosis and responsiveness to immunotherapy in patients with UCEC….FAT2 mutations suggested better OS (p < 0.001) and disease-free survival (DFS) (p = 0.007) in UCEC.